DRMref: comprehensive reference map of drug resistance mechanisms in human cancer
Open Access
- 20 November 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (D1) , D1253-D1264
Abstract
Drug resistance poses a significant challenge in cancer treatment. Despite the initial effectiveness of therapies such as chemotherapy, targeted therapy and immunotherapy, many patients eventually develop resistance. To gain deep insights into the underlying mechanisms, single-cell profiling has been performed to interrogate drug resistance at cell level. Herein, we have built the DRMref database (https://ccsm.uth.edu/DRMref/) to provide comprehensive characterization of drug resistance using single-cell data from drug treatment settings. The current version of DRMref includes 42 single-cell datasets from 30 studies, covering 382 samples, 13 major cancer types, 26 cancer subtypes, 35 treatment regimens and 42 drugs. All datasets in DRMref are browsable and searchable, with detailed annotations provided. Meanwhile, DRMref includes analyses of cellular composition, intratumoral heterogeneity, epithelial–mesenchymal transition, cell–cell interaction and differentially expressed genes in resistant cells. Notably, DRMref investigates the drug resistance mechanisms (e.g. Aberration of Drug’s Therapeutic Target, Drug Inactivation by Structure Modification, etc.) in resistant cells. Additional enrichment analysis of hallmark/KEGG (Kyoto Encyclopedia of Genes and Genomes)/GO (Gene Ontology) pathways, as well as the identification of microRNA, motif and transcription factors involved in resistant cells, is provided in DRMref for user’s exploration. Overall, DRMref serves as a unique single-cell-based resource for studying drug resistance, drug combination therapy and discovering novel drug targets.Keywords
Funding Information
- National Institutes of Health (R01GM123037, U01AR069395, R01CA241930)
- National Science Foundation (2217515, 2326879)
- National Institute of General Medical Sciences (R35GM151089, R35GM138184)
This publication has 65 references indexed in Scilit:
- CancerDR: Cancer Drug Resistance DatabaseScientific Reports, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung CancerCancer Research and Treatment, 2012
- Clinicopathological significance of SOX4 expression in primary gallbladder carcinomaDiagnostic Pathology, 2012
- IGFBP-3 Is a Metastasis Suppression Gene in Prostate CancerCancer Research, 2011
- Identification of a Novel Cell Death Receptor Mediating IGFBP-3-induced Anti-tumor Effects in Breast and Prostate CancerJournal of Biological Chemistry, 2010
- mRNA-Seq whole-transcriptome analysis of a single cellNature Methods, 2009
- EMT, the cytoskeleton, and cancer cell invasionCancer and Metastasis Reviews, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000